These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3141692)

  • 21. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.
    Bar-On H; Roheim PS; Eder HA
    J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D.
    Utermann G; Weber W; Beisiegel U
    FEBS Lett; 1979 May; 101(1):21-6. PubMed ID: 221251
    [No Abstract]   [Full Text] [Related]  

  • 23. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
    Utermann G; Jaeschke M; Menzel J
    FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
    [No Abstract]   [Full Text] [Related]  

  • 24. Adult xanthogranulomatosis associated with abnormal plasma apolipoprotein levels.
    Bergman R; Friedman-Birnbaum R; Aviram M; Katz I; Kerner H; Brook JG
    Clin Exp Dermatol; 1990 Sep; 15(5):372-5. PubMed ID: 2225543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
    Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
    Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein A-II can incorporate into plasma very low density lipoproteins.
    Mao SJ; Kluge K; Squillace SJ
    FEBS Lett; 1981 Sep; 132(2):289-92. PubMed ID: 6795063
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isoelectric focusing of apolipoproteins E in the VLDL lipoprotein fraction in the diagnosis of type III lipoproteinemia].
    Naruszewicz M; Nowicka G; Wiśniewska B; Kłosiewicz-Latoszek L
    Pol Arch Med Wewn; 1982; 67(5-6):235-41. PubMed ID: 7177885
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinaemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Eur J Clin Invest; 1984 Jun; 14(3):219-26. PubMed ID: 6432551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in plasma apolipoproteins following whole-body irradiation in rabbit.
    Feliste R; Dousset N; Carton M; Douste-Blazy L
    Radiat Res; 1981 Sep; 87(3):602-12. PubMed ID: 7280189
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro metabolism of apolipoprotein E.
    Rubinstein A; Gibson JC; Ginsberg HN; Brown WV
    Biochim Biophys Acta; 1986 Dec; 879(3):355-61. PubMed ID: 3778925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of apolipoprotein E-containing lipoproteins.
    Weisgraber KH; Mahley RW
    Methods Enzymol; 1986; 129():145-66. PubMed ID: 3724537
    [No Abstract]   [Full Text] [Related]  

  • 38. On the polypeptide composition of an abnormal high density lipoprotein (LP-E) occurring in LCAT-deficient plasma.
    Langer KH; Utermann G; Menzel HJ
    FEBS Lett; 1974 Sep; 45(1):29-32. PubMed ID: 4370240
    [No Abstract]   [Full Text] [Related]  

  • 39. A rapid micromethod for apolipoprotein E phenotyping directly in serum.
    Havekes LM; de Knijff P; Beisiegel U; Havinga J; Smit M; Klasen E
    J Lipid Res; 1987 Apr; 28(4):455-63. PubMed ID: 3585179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.